Evidence map›Paper›PMID 33087083›Full record

Trial reportBMC public health2020

The effects of financial incentives on diabetes prevention program attendance and weight loss among low-income patients: the We Can Prevent Diabetes cluster-randomized controlled trial.

Jay R Desai, Gabriela Vazquez-Benitez, Gretchen Taylor, Sara Johnson, Julie Anderson, Joyce E Garrett, Todd Gilmer, Houa Vue-Her, Sarah Rinn, Katelyn Engel and 2 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02422420 (Minnesota Medicaid Incentives to Prevent Chronic Disease), which is not on this map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02422420 nacompletednot on this map

Minnesota Medicaid Incentives to Prevent Chronic Disease

TypeinterventionalSponsorMinnesota Department of Human ServicesRan2013 to 2016Enrolled1,500ConditionsPrediabetic StateArmsFinancial Incentives
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Prevention of Type 2 Diabetes.Endocrinology and metabolism clinics of North America · 2021
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jay R DesaiHealthPartners Institute, Bloomington, MN, USA. Jay.Desai@state.mn.us.ORCID http://orcid.org/0000-0002-3010-8501
Gabriela Vazquez-BenitezHealthPartners Institute, Bloomington, MN, USA.
Gretchen TaylorMinnesota Department of Health, 85 East 7th Place, P.O. Box 64882, St. Paul, MN, 55164, USA.
Sara JohnsonMinnesota Department of Health, 85 East 7th Place, P.O. Box 64882, St. Paul, MN, 55164, USA.
Julie AndersonMinnesota Department of Health, 85 East 7th Place, P.O. Box 64882, St. Paul, MN, 55164, USA.
Joyce E GarrettMinnesota Department of Human Services, St. Paul, MN, USA.
Todd GilmerUniversity of California, La Jolla, San Diego, CA, USA.
Houa Vue-HerMinnesota Department of Health, 85 East 7th Place, P.O. Box 64882, St. Paul, MN, 55164, USA.
Sarah RinnMinnesota Department of Human Services, St. Paul, MN, USA.
Katelyn EngelNational Kidney Foundation, New York, NY, USA.
Jeff SchiffMinnesota Department of Human Services, St. Paul, MN, USA.
Patrick J O'ConnorHealthPartners Institute, Bloomington, MN, USA.

Funding

Centers for Medicare and Medicaid Services 1BCMS330901NIDDK NIH HHS P30DK092928
6 · The paper itself

Abstract

backgroundPenetration and participation of real life implementation of lifestyle change programs to prevent type 2 diabetes has been challenging. This is particularly so among low income individuals in the United States. The purpose of this study is to examine the effectiveness of financial incentives on attendance and weight loss among Medicaid beneficiaries participating in the 12-month Diabetes Prevention Program (DPP).

methodsThis is a cluster-randomized controlled trial with two financial incentive study arms and an attention control study arm. Medicaid beneficiaries with prediabetes from 13 primary care clinics were randomly assigned to individually earned incentives (IND; 33 groups; n = 309), a hybrid of individual- and group-earned incentives (GRP; 30 groups; n = 259), and an attention control (AC; 30 groups; n = 279). Up to $520 in incentives could be earned for attaining attendance and weight loss goals over 12 months. Outcomes are percent weight loss from baseline, achieving 5% weight loss from baseline, and attending 75% of core and 75% of maintenance DPP sessions. Linear mixed models were used to examine weight change and attendance rates over the 16 weeks and 12 months.

resultsThe percent weight change at 16 weeks for the IND, GRP, and AC participants were similar, at - 2.6, - 3.1%, and - 3.4%, respectively. However, participants achieving 5% weight loss in the IND, GRP, and AC groups was 21.5, 24.0% (GRP vs AC, P < 0.05), and 15.2%. Attendance at 75% of the DPP core sessions was significantly higher among IND (60.8%, P < 0.001) and GRP (64.0%, P < 0.001) participants than among AC (38.6%) participants. Despite substantial attrition over time, attendance at 75% of the DPP maintenance sessions was also significantly higher among IND (23.0%, P < 0.001) and GRP (26.1%, P < 0.001) participants than among AC (11.0%) participants.

conclusionsFinancial incentives can improve the proportion of Medicaid beneficiaries attending the 12-month DPP and achieving at least 5% weight loss.

trial registrationClinicalTrials.gov NCT02422420 ; retrospectively registered April 21, 2015.

Indexed as

Diabetes Mellitus, Type 2Prediabetic StateHumansLife StyleMotivationUnited StatesWeight LossDiabetes type 2 preventionFinancial incentivesLifestyle interventionLow income individualsMedicaidWeight loss

Identifiers

PMID33087083
PMCPMC7580006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.